| |
| |
|
| Insider
Information: |
Nguyen Tran |
| Relationship: |
|
| City: |
La Jolla |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,200 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$69,376 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,200 |
|
|
| Total
Value |
$69,376 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
SVP and CFO |
2013-03-06 |
0 |
2010-04-12 |
0 |
Premium* |
|
|
Prothena Corp Plc |
PRTA |
|
2023-05-17 |
3,200 |
2014-05-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRTA |
Prothena Corp Plc |
Chief Strategy Officer and CFO |
• – – |
2022-07-21 |
4 |
OE |
$6.73 |
$138,369 |
D/D |
20,560 |
23,760 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Vice President and CFO |
• – – |
2010-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP and CFO |
• – – |
2012-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
52,617 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chief Financial Officer |
• – – |
2015-12-09 |
4 |
AS |
$65.46 |
$1,984,975 |
D/D |
(30,000) |
2,200 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chief Financial Officer |
• – – |
2015-12-09 |
4 |
OE |
$6.73 |
$201,900 |
D/D |
30,000 |
32,200 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chief Strategy Officer and CFO |
• – – |
2022-07-20 |
4 |
AS |
$32.32 |
$1,368,441 |
D/D |
(42,120) |
3,200 |
0 |
% |
|
| PRTA |
Prothena Corp Plc |
Chief Strategy Officer and CFO |
• – – |
2022-07-20 |
4 |
OE |
$6.73 |
$283,468 |
D/D |
42,120 |
45,320 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP and CFO |
• • – |
2013-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,419) |
0 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP and CFO |
• – – |
2011-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
107,500 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chief Strategy Officer and CFO |
• • – |
2023-05-17 |
4 |
OE |
$22.85 |
$2,483,950 |
D/D |
95,000 |
98,200 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chief Strategy Officer and CFO |
• • – |
2023-05-17 |
4 |
AS |
$72.66 |
$7,028,921 |
D/D |
(95,000) |
3,200 |
0 |
% |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
